The first demonstration of successful treatment of the current outbreak strain of Ebola virus in non-human primates using an experimental drug called TKM-Ebola is reported in a small study involving six rhesus monkeys, published in Nature this week. Versions of thetherapy have been used on compassionate grounds in a number of human patients in the current outbreak, although the efficacy in humans is not known as the experimental drugs have been used in combination with other treatments. The drug can be adapted to target a specific strain of Ebola virus and can be produced in as little as eight weeks.                                  Access the paper online and visit Nature's Ebola Special for up-to-date coverage of the crisis.  |                              
No comments:
Post a Comment